Promoter group creates encumbrance over full 47.02 percent GTBL stake

Pledge Above 50pctPromoter Below 50pctOwnership Changes View source PDF

GUJTHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-2.6%1-day move

₹383.00

prior close

—

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————-2.6-2.8-4.1-5.2-4.3-6.2————

Up moveDown movePending

AI summary

Promoter group entity Pharmaceutical Business Group (India) Ltd [PBGIL] disclosed creation of indirect encumbrance over its entire 47.02 percent stake, that is 5,12,40,000 shares, in Gujarat Themis Biosyn. The encumbrance arises because Vividhmargi Investments pledged 51 percent of PBGIL shares and gave a non-disposal undertaking on 47.98 percent of PBGIL shares in favour of CTL Trusteeship Ltd as debenture trustee, linked to a debenture trust deed dated June 25, 2026.

Likely market impact

Entire promoter stake is now encumbered. Linked to debenture financing, but could pressure shares if obligations are not met.